title: Determinants and consequences of differences in quality of anticoagulation therapy with vitamin K antagonists.
authors.affiliation: K.G. Jebsen Thrombosis Research and Expertise Centre (TREC), Department of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway; Division of Haemostasis and Thrombosis, Department of Haematology, University Medical Centre Groningen, Groningen, the Netherlands. Electronic address: ynse.i.tichelaar@uit.no.
authors.forename: Vladimir
authors.initials: V
authors.lastname: Tichelaar
authors.affiliation: Division of Haemostasis and Thrombosis, Department of Haematology, University Medical Centre Groningen, Groningen, the Netherlands.
authors.forename: Karina
authors.initials: K
authors.lastname: Meijer
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D015331:Cohort Studies; D006801:Humans; D012189:Retrospective Studies; D020246:Venous Thrombosis / Q000188:drug therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D000925:Anticoagulants; D014812:Vitamin K
keywords: Atrial fibrillation; DOACs; Quality; Venous thrombosis; Vitamin K antagonists; iTTR